Aurigene - Your Research Partner in Drug Discovery and Development
Established in 2002, Aurigene is a specialized drug discovery biotech, focusing on oncology, inflammation and infectious diseases with deep target and therapeutic area expertise. Based in Bangalore, Hyderabad (India) and Kuala Lumpur, Aurigene has a fully integrated drug discovery infrastructure from hit generation to pre-clinical development.
With Universities increasingly moving towards development of commercially validated and attractive technologies, there is an increasing demand for medicinal chemistry, ADME/ PK and efficacy studies from experienced partners. This is especially true when many academic labs are generally constrained for resources.
Aurigene provides a unique model catered to such academic groups recognizing their need for nimble yet cost-efficient services. They have been successful in forging partnerships with several renowned and recognized research labs around the world. Here again, unlike CRO relationships, Aurigene’s expertise, and customized approach to the projects provides the greatest benefit to the scientist partners in Academia/University settings.
In this seminar, Dr. Bhavesh will discuss the potential model of collaboration with Aurigene using the examples of their partnerships with Academic labs in Australia (small molecule FTE chemistry services); US (DMPK services/hit validation projects) and Malaysia (Preclinical and chemistry services).
Dr. Bhavesh Choudhary has completed his PhD from Freie University, Germany and Post doc from Karolinska Institute, Sweden in Oncology and Immuno-oncology field. He has more than 10 years of Biomedical research experience in NCE and NBE area, working in various pharma and Biotech companies. Currently, he is working as research head in Aurigene KL.